Kovo HealthTech Corporation announced that Mr. Greg Noble has stepped down as Chief Executive Officer and that the Board of Directors has selected Brenner Adams to succeed Mr. Noble as interim CEO. During his tenure, Mr. Noble led the Company's public listing on the TSX Venture Exchange and oversaw several acquisitions and operational efficiencies that grew the company from $1.7 million to $10.0 million from Fiscal 2019 to Fiscal 2023. Whereas Mr. Noble is departing as CEO, he has signed a long-term contract to provide M&A consulting services for the Company.

Stepping into the CEO position, Brenner Adams is an international executive with a robust background in business development, marketing, and product leadership who significantly impacted the healthcare industry during his tenure as Chief Innovation Officer at Med USA, a Revenue Cycle Management and Credentialing Services company. Additionally, Adams helped launch two successful spinoffs, with one securing public state funding in the process. The Board believes Adams is well-equipped to ensure a seamless transition and continue the company's aggressive growth trajectory.